eli lilly glp-1 analog Ozempic and Other Drugs to Treat Diabetes Are Now Being Used Weight Loss As GLP-1 Use Expands, Long-Term
Description
Novo-Nordisk A/S, Eli Lilly And Company, Sanofi, AstraZeneca, Pfizer Inc., Amgen, Inc., and Innovent Biologics, Inc

In a randomized phase 3a study published in Diabetes Care, those taking oral semaglutide monotherapy experienced superior and clinically significant improvements in A1c and weight loss compared to those taking Continue reading Oral GLP-1 RA lowers Weight and A1c

Learn more from an expert in the field.
A runny nose during GLP-1 therapy raises questions about whether the medication itself causes nasal symptoms or if other factors are at play
Let our attorneys put their experience with Synjardy lawsuits to work for you
